Delivery Order SPE2DB22D3102-SPE2DB25FL3EP
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Carvedilol ER 10 mg capsules in quantities of 30 units. This contract is a firm fixed-price delivery order with a ceiling value of $8,619.00 and an ultimate completion date of August 8, 2025. The award was made through open competition with no set-aside designation, and performance will be executed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Carvedilol ER 10 mg capsules (30-count units) with a ceiling value of $3,309.42 under firm fixed price terms. The order is scheduled for completion by September 19, 2025, and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. This is a non-set-aside competitive award issued as a child order under AmerisourceBergen's larger indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Carvedilol ER 10 mg capsules (30-count packages) with a ceiling value of $5,976.74. This is a firm fixed price delivery order with an ultimate completion date of June 20, 2025, and represents a non-set-aside competitive award. The contractor's place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Carvedilol ER 10 mg capsules (30-count units) with a contract ceiling value of $2,300.88. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of September 9, 2025. This delivery...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Carvedilol ER 10 mg capsules (30-count packaging). The contract is valued at $9,434.27 under a firm fixed-price arrangement with an ultimate completion date of August 15, 2025. This delivery order was awarded competitively with no set-aside designation and represents performance at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Carvedilol ER 20 mg capsules in 30-count quantities, with a ceiling value of $14,592.37. This is a firm fixed price delivery order with no set-aside designation, executed as a competitive award under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. The contract performance location is AmerisourceBergen's corporate office in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 8, 2025, for the supply of Carvedilol ER 10 mg capsules (30-count units) under a firm fixed-price contract with a ceiling value of $4,687.29. This is a non-set-aside, competitively awarded delivery order with an ultimate completion date of May 9, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Carvedilol ER 20 mg capsules (30-count) with a contract ceiling value of $2,339.36. This is a firm fixed-price delivery order with no set-aside designation, executed through open competition. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The contract has an ultimate completion date...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Carvedilol ER 10 mg capsules in quantities of 30 units. This is a firm fixed price delivery order valued at $4,591.90, with an ultimate completion date of September 3, 2025. The award is a non-set-aside contract and represents a competitive procurement for pharmaceutical supply to support federal medical requirements. Performance will be executed from AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Carvedilol ER 40 mg capsules (30-count units) with a contract value of $4,019.94 and a completion date of September 22, 2025. This is a firm fixed-price, non-competitive set-aside delivery order utilizing AmerisourceBergen's existing indefinite delivery contract vehicle with DLA Troop Support Medical. The order will be fulfilled at the contractor's facility in...
- SPE2DB22D3102Indefinite Delivery Contract
- SPE2DB22D3102-SPE2DB25FL3EPDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Carvedilol ER 10 mg capsules in quantities of 30 units. This is a firm fixed-price delivery order with a ceiling value of $2,185.41 and an ultimate completion date of September 23, 2025. The contract was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. The parent IDC serves as a comprehensive pharmaceutical support vehicle enabling AmerisourceBergen Drug Corp to supply a broad range of medications, vaccines, medical devices, and healthcare commodities to support military and federal healthcare systems worldwide. Carvedilol ER, a cardiovascular medication, represents the type of pharmaceutical product routinely procured through this vehicle to support Defense Health Agency and other federal healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 9/22/25 |